Furthermore, cognitive decline with lorazepam in individuals with higher risk for AD (carriers of APOE-epsilon4 allele, a common AD susceptibility gene) has been reported in a double-blind crossover study (Stonnington et al., 2009). The gene discussed is APOE; the disease is Mental deterioration.